Rashesh Sanghvi

Rashesh Sanghvi

Auto-generated profile, based on publicly available information

Rashesh Sanghvi

Cancer Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2021 in Nature
Verified
Journal Article
Closed access
PDF file
LMLuiza Moore
Luiza Moore
ACAlex Cagan
Alex Cagan
TCTim H. H. Coorens
Tim H. H. Coorens
MNMatthew D. C. Neville
Matthew D. C. Neville
RSRashesh Sanghvi
Rashesh Sanghvi
RRRaheleh Rahbari
Raheleh Rahbari

10 March 2021 in Nature
Verified
Journal Article
Closed access
PDF file
TCTim H. H. Coorens
Tim H. H. Coorens
TOThomas R. W. Oliver
Thomas R. W. Oliver
RSRashesh Sanghvi
Rashesh Sanghvi
USUlla Sovio
Ulla Sovio
ECEmma Cook
Emma Cook
SBSam Behjati
Sam Behjati

25 August 2021 in Nature
Verified
Journal Article
Open access
PDF file
TCTim H. H. Coorens
Tim H. H. Coorens
LMLuiza Moore
Luiza Moore
PRPhilip S. Robinson
Philip S. Robinson
RSRashesh Sanghvi
Rashesh Sanghvi
JCJoseph Christopher
Joseph Christopher
MSMichael R. Stratton
Michael R. Stratton
Starting from the zygote, all cells in the human body continuously acquire mutations. Mutations shared between different cells imply a common progenitor and are thus naturally occurring markers for lineage tracing1,2. Here we reconstruct extensive phylogenies of normal tissues from three adult individuals using whole-genome sequencing of 511 laser capture microdissections. Reconstructed embryonic progenitors in the same generation of a phylogeny often contribute to different extents to the adult body. The degree of this asymmetry varies between individuals, with ratios between the two reconstructed daughter cells of the zygote ranging from 60:40 to 93:7. Asymmetries pervade subsequent generations and can differ between tissues in the same individual. The phylogenies resolve the spatial embryonic patterning of tissues, revealing contiguous patches of, on average, 301 crypts in the adult colonic epithelium derived from a most recent embryonic cell and also a spatial effect in brain development. Using data from ten additional men, we investigated the developmental split between soma and germline, with results suggesting an extraembryonic contribution to primordial germ cells. This research demonstrates that, despite reaching the same ultimate tissue patterns, early bottlenecks and lineage commitments lead to substantial variation in embryonic patterns both within and between individuals.

11 May 2022 in Nature
Verified
Journal Article
Open access
PDF file
JKJoanna Kaplanis
Joanna Kaplanis
BIBenjamin Ide
Benjamin Ide
RSRashesh Sanghvi
Rashesh Sanghvi
MNMatthew Neville
Matthew Neville
PDPetr Danecek
Petr Danecek
MHMatthew Hurles
Matthew Hurles
Mutations in the germline generates all evolutionary genetic variation and is a cause of genetic disease. Parental age is the primary determinant of the number of new germline mutations in an individual’s genome1,2. Here we analysed the genome-wide sequences of 21,879 families with rare genetic diseases and identified 12 individuals with a hypermutated genome with between two and seven times more de novo single-nucleotide variants than expected. In most families (9 out of 12), the excess mutations came from the father. Two families had genetic drivers of germline hypermutation, with fathers carrying damaging genetic variation in DNA-repair genes. For five of the families, paternal exposure to chemotherapeutic agents before conception was probably a key driver of hypermutation. Our results suggest that the germline is well protected from mutagenic effects, hypermutation is rare, the number of excess mutations is relatively modest and most individuals with a hypermutated genome will not have a genetic disease.

8 October 2025 in Nature
Verified
Journal Article
Open access
PDF file
MNMatthew D. C. Neville
Matthew D. C. Neville
ALAndrew R. J. Lawson
Andrew R. J. Lawson
RSRashesh Sanghvi
Rashesh Sanghvi
FAFederico Abascal
Federico Abascal
MPMy H. Pham
My H. Pham
RRRaheleh Rahbari
Raheleh Rahbari
Mutations that occur in the cell lineages of sperm or eggs can be transmitted to offspring. In humans, positive selection of driver mutations during spermatogenesis can increase the birth prevalence of certain developmental disorders 1–3 . Until recently, characterizing the extent of this selection in sperm has been limited by the error rates of sequencing technologies. Here we used the duplex sequencing method NanoSeq 4 to sequence 81 bulk sperm samples from individuals aged 24–75 years. Our findings revealed a linear accumulation of 1.67 (95% confidence interval of 1.41–1.92) mutations per year per haploid genome driven by two mutational signatures associated with human ageing. Deep targeted and exome NanoSeq 5 of sperm samples identified more than 35,000 germline coding mutations. We detected 40 genes (31 newly identified) under significant positive selection in the male germline that have activating or loss-of-function mechanisms and are involved in diverse cellular pathways. Most of the positively selected genes are associated with developmental or cancer predisposition disorders in children, whereas four of the genes exhibited increased frequencies of protein-truncating variants in healthy populations. We show that positive selection during spermatogenesis drives a 2–3-fold increased risk of known disease-causing mutations, which results in 3–5% of sperm from middle-aged to older individuals with a pathogenic mutation across the exome. These findings shed light on germline selection dynamics and highlight a broader increased disease risk for children born to fathers of advanced age than previously appreciated.

1 July 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
EMEmily Mitchell
Emily Mitchell
MPMy H. Pham
My H. Pham
ACAnna Clay
Anna Clay
RSRashesh Sanghvi
Rashesh Sanghvi
NWNicholas Williams
Nicholas Williams
MSMichael R. Stratton
Michael R. Stratton
Several chemotherapeutic agents act by increasing DNA damage in cancer cells, triggering cell death. However, there is limited understanding of the extent and long-term consequences of collateral DNA damage in normal tissues. To investigate the impact of chemotherapy on mutation burdens and the cell population structure of normal tissue, we sequenced blood cell genomes from 23 individuals aged 3–80 years who were treated with a range of chemotherapy regimens. Substantial additional somatic mutation loads with characteristic mutational signatures were imposed by some chemotherapeutic agents, but the effects were dependent on the drug and blood cell types. Chemotherapy induced premature changes in the cell population structure of normal blood, similar to those caused by normal aging. The results show the long-term biological consequences of cytotoxic agents to which a substantial fraction of the population is exposed as part of disease management, raising mechanistic questions and highlighting opportunities for the mitigation of adverse effects.